Anthem (ANTM): 4 Insights from 2Q - Jefferies

Jefferies analyst, David Windley reiterated his Buy rating on shares of Anthem (NYSE: ANTM) with the stock at the cheapest valuation in the group (<12x '17 P/E). The quarter was tough though with exchanges expected to lose money and Medicaid earnings lower than projected (IA a heavier lift). SG&A cuts bridge the gap. On the positive side, membership and premiums are trending higher. Looking into 2017, Exchange and IA losses should mitigate.

Nonetheless, lower visibility prompts the analyst to trim his PT and EPS projections as the price target falls to $156.00 (from $157.00).

For an analyst ratings summary and ratings history on Anthem click here. For more ratings news on Anthem click here.

Shares of Anthem closed at $133.86 yesterday.

You May Also Be Interested In

• Boston Beer Company (SAM) PT Lowered to $325 at Jefferies
• Spotify (SPOT) PT Raised to $345 at Macquarie
• Wells Fargo Upgrades Neurocrine Bio. (NBIX) to Overweight 'as the Company is Knocking on the Doors of the Large-Cap Club'